Hoechst Pharmaceuticals LLP

Hoechst Pharmaceuticals LLP - business services in Delhi, India. FY 2026 financials & compliance.
LLPIN ABA-9921 Incorporated 12 May 2022 ROC Delhi HQ Delhi, India
Active Limited Liability Partnership business services
Data last updated
Revenue · FY 2023
₹89.02 Lakh
Latest filing
Net profit · FY 2023
₹1.58 Lakh
Net margin 1.8%
EBITDA · FY 2023
₹4.08 Lakh
EBITDA margin 4.6%
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹19.34 Lakh
Secured borrowings
LLP age
4 yrs
Est. 2022
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered

About Hoechst Pharmaceuticals LLP

Data last updated:

Hoechst Pharmaceuticals LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the commission-based trading segment of the business services sector. It was incorporated on 12 May 2022.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN ABA-9921. Its GSTIN is 07AAOFH9243A1ZE (Delhi).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Kapil Kumar Bhawarlal Jain and Soniya Soniya.

Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at No. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹89.02 Lakh. For the same year it recorded a net profit of ₹1.58 Lakh (net margin 1.8%) and EBITDA of ₹4.08 Lakh (EBITDA margin 4.6%).

As per MCA filings, the LLP has open charges of ₹19.34 Lakh on record.

Company Details of Hoechst Pharmaceuticals LLP
LLPIN ABA-9921
Incorporation Date 12 May 2022
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Company Status Active
Date of Last AGM 31 March 2023
Date of Balance Sheet 31 March 2023
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    No. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034
  • Industry
    Business Services, Commission Trade
Comprehensive company report
Hoechst Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Hoechst Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Hoechst Pharmaceuticals LLP in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Financials of Hoechst Pharmaceuticals LLP FY 2023 filings available

Hoechst Pharmaceuticals LLP reported revenue of ₹89.02 Lakh for FY 2023.

Revenue · FY 2023
₹89.02 Lakh
Net profit · FY 2023
₹1.58 Lakh margin 1.8%
EBITDA · FY 2023
₹4.08 Lakh margin 4.6%

Financial Statement Summary of Hoechst Pharmaceuticals LLP

Statement of Account and SolvencyFY 2022-23
Income and Expenditure
Turnover₹89.02 Lakh
Other Income••••
Total Income••••
Purchases and Direct Costs••••
Personnel Expenses••••
Administrative Expenses••••
Interest••••
Depreciation••••
Total Expenses••••
Profit Before Tax••••
Tax••••
Profit After Tax₹1.58 Lakh
Profit Transferred to Partners••••
Assets and Liabilities
Partners' Contribution••••
Reserves and Surplus••••
Secured Loans••••
Unsecured Loans••••
Trade Payables••••
Other Liabilities and Provisions••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Loans and Advances••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Hoechst Pharmaceuticals LLP

Statement of Account and SolvencyFY 2022-23
Profitability
Net Profit Margin1.8%
Return on Partners' Funds••••
Return on Assets••••
Liquidity and Debt
Current Ratio••••
Debt to Partners' Funds••••
Interest Coverage••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Turnover Growth••••
Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Hoechst Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Hoechst Pharmaceuticals LLP

Hoechst Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Kapil Kumar Bhawarlal JainDesignated Partner12 May 20224 Years 5 MonthsCurrent
Soniya SoniyaDesignated Partner12 May 20224 Years 5 MonthsCurrent

Ownership and Shareholding of Hoechst Pharmaceuticals LLP

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Hoechst Pharmaceuticals LLP

Open charges
₹19.34 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.19 Cr
Latest charge details
DateLenderAmountStatus
02 Jan 2023Hdfc Bank Limited₹19.34 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Hoechst Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Hoechst Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Hoechst Pharmaceuticals LLP

Hoechst Pharmaceuticals LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Kapil Kumar Bhawarlal Jain was appointed as Designated Partner on 12 May 2022.

AGM
Hoechst Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Filing
Hoechst Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 19.34 Lakh with Charge ID 100757322 was registered on 02 Jan 2023.
Appointed
Kapil Kumar Bhawarlal Jain was appointed as Designated Partner.
Appointed
Soniya Soniya was appointed as Designated Partner.
Incorporation
12 May 2022
Hoechst Pharmaceuticals Llp was registered on 12 May 2022 with Roc Delhi & aged 4 years 5 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Hoechst Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hoechst Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hoechst Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Hoechst Pharmaceuticals LLP

Hoechst Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAOFH9243A1ZEDelhiActive05 Jul 2022
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hoechst Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hoechst Pharmaceuticals LLP

Hoechst Pharmaceuticals is an active limited liability partnership based in Delhi, India. The LLP works in commission trade, within the business services industry. It was incorporated on 12 May 2022 (4+ years old) and is registered under LLPIN ABA-9921.

Hoechst Pharmaceuticals reported revenue of ₹89.02 Lakh for FY 2023.

Hoechst Pharmaceuticals has 2 current designated partners:

Hoechst Pharmaceuticals reported a net profit of ₹1.58 Lakh (net margin 1.8%) and EBITDA of ₹4.08 Lakh (EBITDA margin 4.6%) for FY 2023, as per its filed financial statements.

The GSTIN of Hoechst Pharmaceuticals is 07AAOFH9243A1ZE, registered in Delhi.

The LLPIN (Limited Liability Partnership Identification Number) of Hoechst Pharmaceuticals is ABA-9921. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Hoechst Pharmaceuticals was incorporated on 12 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

Kapil Kumar Bhawarlal Jain was appointed as Designated Partner on 12 May 2022. Soniya Soniya was appointed as Designated Partner on 12 May 2022.

The registered office of Hoechst Pharmaceuticals is at No. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034.

The total obligation of contribution is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available